Oncology care coordination program for Native American patients
Official title: Care Coordination and Communication Program in Oncology for Tribal Health Systems (C3PO)
Run by University of Oklahoma · NCT07217574 · Data updated 2026-11-12
This project will test whether a coordinated care and navigation program (C3PO) helps Native American adults newly diagnosed with cancer communicate with care teams and report better outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 187 (estimated) |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Status | Recruiting |
| Started | February 11, 2026 |
| Main results expected | March 2030 |
| Study ends | March 2031 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07217574 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Native American adults (18+) within eight weeks of a new cancer diagnosis who are navigated through the NANP at OU Health Stephenson Cancer Center and speak English fluently.
✕Probably not a fit
People who are not Native American, diagnosed more than eight weeks earlier, not enrolled in the NANP navigation program, non-English speakers, or who participated in the Phase I pilot (and are therefore ineligible for Phase II) may not receive benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program uses a two-phase approach enrolling Native American adults with newly diagnosed cancer who are navigated through the NANP at OU Health Stephenson Cancer Center. Phase I is a 3-month pilot with up to 15 participants completing baseline assessments, monthly surveys, and exit interviews to refine the intervention. Phase II is a randomized trial comparing the C3PO care coordination intervention to usual navigation services, with all participants offered C3PO after six months. C3PO meetings focus on treatment side effects, comorbidities, approvals for referred care, and practical barriers such as transportation and financial hardship.
Why it matters
Potential benefit: If successful, this program could reduce care barriers, improve symptom management, and lead to better patient-reported outcomes for Native American cancer patients.
How similar studies have gone: Care navigation and coordination programs have improved outcomes in other populations, but a culturally tailored program embedded with tribal health systems like C3PO is relatively novel and not extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be at least 18 years of age, within eight weeks of newly diagnosed cancer confirmed by pathology/imaging, navigated through the NANP at SCC and have verbal fluency in English. Exclusion Criteria: * Participants in the Phase 1 open pilot will not be eligible for the Phase 2 RCT.
Where it's running
-
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States Recruiting
Study contacts
- Principal investigator: Amanda Janitz, Ph.D. — University of Oklahoma Stephenson Cancer Center
- Study coordinator: Amanda Janitz, Ph.D.
- Email: Amanda-Janitz@ou.edu
- Phone: 405-271-2229
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing Dexamethasone Inserts to Standard Steroid Drops After Eye Surgery
This study is testing whether a new eye insert can work better than regular steroid eye drops for patients recovering from eye surgery.
-
Biopsy-site marker stiffness in breast cancer
This observational study will see if the stiffness of biopsy-site markers relates to inflammation and potential spread in women with breast cancer.
-
Protoacoustic Imaging to See Radiation Delivery in Proton Therapy
This study tests radioacoustic imaging with ultrasound to help doctors see where proton therapy is delivering radiation for liver and prostate cancer patients.
-
Modified FOLFIRINOX with Pentamidine in Advanced Pancreatic Cancer
This study tests whether adding pentamidine to a modified FOLFIRINOX regimen helps people with advanced or metastatic pancreatic cancer.
-
Testing Alcohol Health Warning Labels for US Adults
A randomized online study will test different warning statements about alcohol and breast cancer risk among adult US women who drink or are young non-drinkers to see which warnings are most convincing.
-
Testing warning labels on cannabis packaging to see what design helps people notice risks
Researchers are testing different cannabis warning labels to see which designs make people notice health risks and think about their use more carefully.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.